These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6248183)

  • 1. Multicentricity of non-palpable breast cancer.
    Schwartz GF; Patchesfsky AS; Feig SA; Shaber GS; Schwartz AB
    Cancer; 1980 Jun; 45(12):2913-6. PubMed ID: 6248183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinically occult breast cancer. Multicentricity and implications for treatment.
    Schwartz GF; Patchefsky AS; Feig SA; Shaber GS; Schwartz AB
    Ann Surg; 1980 Jan; 191(1):8-12. PubMed ID: 6243455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of four-quadrant random sections in mastectomy specimens.
    Gupta D; Nath M; Layfield LJ
    Breast J; 2003; 9(4):307-11. PubMed ID: 12846866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conservative surgery for multifocal/multicentric breast cancer.
    Nijenhuis MV; Rutgers EJ
    Breast; 2015 Nov; 24 Suppl 2():S96-9. PubMed ID: 26303986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentricity in nonpalpable breast carcinoma and its implications for treatment.
    Tinnemans JG; Wobbes T; van der Sluis RF; Lubbers EJ; de Boer HH
    Am J Surg; 1986 Mar; 151(3):334-8. PubMed ID: 3006532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifocal, multicentric, and contralateral breast cancers: bilateral whole-breast US in the preoperative evaluation of patients.
    Moon WK; Noh DY; Im JG
    Radiology; 2002 Aug; 224(2):569-76. PubMed ID: 12147858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammographically occult breast cancer. A pathologic and radiologic study.
    Holland R; Hendriks JH; Mravunac M
    Cancer; 1983 Nov; 52(10):1810-9. PubMed ID: 6313174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of Tis/T1 breast cancer extent by multislice helical CT: a novel classification of tumor distribution.
    Tozaki M; Kawakami M; Suzuki M; Uchida K; Yamashita A; Fukuda K
    Radiat Med; 2003; 21(5):187-92. PubMed ID: 14632293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The extent and distribution of cancer in breasts with palpable primary tumors.
    Gump FE; Shikora S; Habif DV; Kister S; Logerfo P; Estabrook A
    Ann Surg; 1986 Oct; 204(4):384-90. PubMed ID: 3021071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of intraductal carcinoma of the breast.
    Patchefsky AS; Schwartz GF; Finkelstein SD; Prestipino A; Sohn SE; Singer JS; Feig SA
    Cancer; 1989 Feb; 63(4):731-41. PubMed ID: 2536585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicentricity and bilaterality in invasive breast carcinoma.
    Lesser ML; Rosen PP; Kinne DW
    Surgery; 1982 Feb; 91(2):234-40. PubMed ID: 6277027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance and staging of nonpalpable carcinomas of the breast.
    Schwartz GF; Feig SA; Patchefsky AS
    Surg Gynecol Obstet; 1988 Jan; 166(1):6-10. PubMed ID: 2827328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonpalpable in situ ductal carcinoma of the breast. Predictors of multicentricity and microinvasion and implications for treatment.
    Schwartz GF; Patchefsky AS; Finklestein SD; Sohn SH; Prestipino A; Feig SA; Singer JS
    Arch Surg; 1989 Jan; 124(1):29-32. PubMed ID: 2535928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically occult breast lesions: localization and significance.
    Rosenberg AL; Schwartz GF; Feig SA; Patchefsky AS
    Radiology; 1987 Jan; 162(1 Pt 1):167-70. PubMed ID: 3024209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathobiology of breast cancer--treatment implications.
    Vorherr H
    Eur J Obstet Gynecol Reprod Biol; 1984 May; 17(2-3):219-35. PubMed ID: 6329835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.
    Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R
    Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of radioactive iodine-125 seed localization in patients with non-palpable breast cancer: a comparison with the radioguided occult lesion localization with 99m technetium.
    van der Noordaa ME; Pengel KE; Groen E; van Werkhoven E; Rutgers EJ; Loo CE; Vogel W; Vrancken Peeters MJ
    Eur J Surg Oncol; 2015 Apr; 41(4):553-8. PubMed ID: 25707349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and survival of female patients with nonpalpable breast carcinoma.
    Tinnemans JG; Wobbes T; Holland R; Hendriks JH; Van der Sluis RF; De Boer HH
    Ann Surg; 1989 Feb; 209(2):249-53. PubMed ID: 2537064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic findings in nonpalpable invasive breast cancer.
    McKinney CD; Frierson HF; Fechner RE; Wilhelm MC; Edge SB
    Am J Surg Pathol; 1992 Jan; 16(1):33-6. PubMed ID: 1309412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of occult invasive breast cancer after excisional biopsy showing in-situ ductal carcinoma of comedo pattern.
    Hardman PD; Worth A; Lee U; Baird RM
    Can J Surg; 1989 Jan; 32(1):56-60. PubMed ID: 2535949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.